Tentarix
Tentarix develops conditionally active multispecific biologics with high therapeutic index for oncology and autoimmune disease.
$50M Series A
Led by Samsara Biocapital · Source: tentarix.com
Latest round on record: Series B+, September 2023, amount undisclosed.
All 2 rounds ↓Signals
Website registeredAug 25, 2011 (15 years old)
About Tentarix
Based in San Diego.
Funding rounds
- Series B+ · amount undisclosedSource: fundraisingfox.com
- Website created
- Date unknownSeries A · $50M
SSamsara Biocapital (lead),
VVersant Ventures (lead)
Source: tentarix.com
Founders and team
MK
Margaret Karow FounderPG
Paul Grayson Founder
Investors
AAmplitude Venture Capital
GGilead Sciences
Companies like Tentarix
GGlycoEra$130M Series B+ · May 2025
AAnaveon$120M Series B+ · Dec 2021
EElixion BiotechPre Seed · May 2026
DDren Bio$350M Series B+ · Oct 2026MMerida Biosciences$120M Series A · May 2025
MMozart Therapeutics$25M Series A · Jun 2023
Other companies backed by Samsara Biocapital
TT-Therapeutics$133M Series B+ · Nov 2026
RR1 Therapeutics$80.5M Series A · Sep 2026
AAbcuro$66M Series B+ · Aug 2026
CClaris Bio$118M Series B+ · Jul 2026
NNura Bio$73.8M Series B+ · Jun 2026
PPsiThera$47.5M Series A · Dec 2025
Samsara Biocapital portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tentarix (get a free API key).